Related Experiment Videos
Is Open Science the Future of Drug Development?
1Yale School of Medicine, Yale University, New Haven, CT.
The Yale Journal of Biology and Medicine
|March 31, 2017
Summary
Open science strategies, including collaboration and data sharing, are improving drug discovery efficiency and ethics. These open approaches offer a more effective path for biomedical research despite potential risks.
Area of Science:
- Biomedical Research
- Drug Development
- Open Science
Background:
- Traditional drug development is costly and inefficient, with stagnant new drug production.
- Rising R&D costs necessitate innovative approaches in the pharmaceutical industry.
Purpose of the Study:
- To explore the impact and benefits of open science strategies in drug discovery.
- To argue for the adoption of open practices as a more efficient and ethical model for biomedical research.
Main Methods:
- Review of open science strategies: collaboration, crowdsourcing, data sharing, and open sourcing.
- Examination of open drug development initiatives (e.g., malaria, tropical diseases).
- Analysis of open practices across the drug discovery pipeline, from target identification to clinical trials.
Main Results:
- Open science practices are increasingly integrated into various stages of drug discovery.
- Initiatives in areas like malaria and tropical diseases demonstrate the potential of open drug development.
- Open science offers potential solutions to enhance efficiency and ethical considerations in research.
Conclusions:
- Open science, despite risks like data management and protection, presents a more efficient and ethical model for biomedical research.
- Embracing open strategies can reshape the pharmaceutical industry towards greater innovation and public engagement.